NEWAS
AVXL icon

N.E.W. Advisory Services’s Anavex Life Sciences AVXL Stock Holding History

N.E.W. Advisory Services’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.3K Hold
5,893
– – ﹤0.01% 583
2026
Q1 		$18.1K Buy
5,893
+3,600
+157% +$15.6K ﹤0.01% 524
2025
Q4 		$8.16K Hold
2,293
– – ﹤0.01% 647
2025
Q3 		$20.4K Hold
2,293
– – ﹤0.01% 465
2025
Q2 		$21.1K Hold
2,293
– – ﹤0.01% 452
2025
Q1 		$19.7K Buy
+2,293
New +$21.7K ﹤0.01% 499

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

N.E.W. Advisory Services's AVXL Position: Q2 2026 in Review

N.E.W. Advisory Services held its Anavex Life Sciences (AVXL) position steady in Q2 2026 at 5,893 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #583.

N.E.W. Advisory Services first reported a position in AVXL in Q1 2025 and has held it in 6 quarters since. The position peaked at $21.1K in Q2 2025. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • N.E.W. Advisory Services held 5,893 shares of Anavex Life Sciences worth $15.3K as of Q2 2026.
  • N.E.W. Advisory Services left its Anavex Life Sciences share count unchanged in Q2 2026.
  • Anavex Life Sciences made up ﹤0.01% of N.E.W. Advisory Services's portfolio in Q2 2026, its #583 holding.
  • N.E.W. Advisory Services first reported a position in Anavex Life Sciences in Q1 2025 and has held it in 6 quarters since.
  • N.E.W. Advisory Services's Anavex Life Sciences position peaked at $21.1K in Q2 2025.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on N.E.W. Advisory Services's 13F filing for Q2 2026, filed 6 Aug 2026.